Pulmonx (LUNG) Long-Term Investments (2021 - 2025)

Pulmonx (LUNG) has reported Long-Term Investments for 5 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Long-Term Investments rose 114.4% year-over-year to $3.6 million in Q4 2025; TTM through Dec 2025 was $3.6 million, a 114.4% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 114.4% from the prior year.
• Long-Term Investments was $3.6 million for Q4 2025 at Pulmonx, up from $2.5 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $23.3 million in Q3 2023 and troughed at $1.4 million in Q1 2025.
• A 5-year average of $5.7 million and a median of $3.9 million in 2024 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments jumped 410.44% in 2023 and slumped 90.26% in 2024, its largest moves.
• Over 5 years, Long-Term Investments stood at $10.9 million in 2021, then sank by 45.86% to $5.9 million in 2022, then soared by 142.91% to $14.4 million in 2023, then plunged by 88.32% to $1.7 million in 2024, then jumped by 114.4% to $3.6 million in 2025.
• The last three Long-Term Investments figures came in at $3.6 million (Q4 2025), $2.5 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.